US 11078239
Prefusion PIV F immunogens and their use
granted A61KA61K39/12A61K39/155
Quick answer
US patent 11078239 (Prefusion PIV F immunogens and their use) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K39/12, A61K39/155, A61P, A61P31/14